![Shannon Morris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shannon Morris
Technik-/Wissenschafts-/F&E-Leiter bei
ERASCA, INC.
Vermögen: - $ am 31.05.2026
Profil
Shannon R.
Morris is President & Partner at Sigma Group, Inc. since 2011.
Dr. Morris is Chief Medical Officer at Erasca, Inc. since 2023.
Former roles include Senior Director at MedImmune LLC from 2014 to 2017, Vice President-Clinical Development at G1 Therapeutics, Inc. from 2017 to 2020, and Vice President & Head-Clinical Development at Istari Oncology, Inc. from 2020 to 2022.
Education includes undergraduate studies at Stanford University and a doctorate from Case Western Reserve University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ERASCA, INC. -.--% | 15.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Shannon Morris
| Unternehmen | Position | Beginn |
|---|---|---|
| ERASCA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.05.2022 |
Sigma Group, Inc.
 Sigma Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising services | Präsident | - |
Ehemalige bekannte Positionen von Shannon Morris
| Unternehmen | Position | Ende |
|---|---|---|
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
| G1 THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direktor/Vorstandsmitglied | 01.03.2017 |
Ausbildung von Shannon Morris
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigma Group, Inc.
Sigma Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising services | Commercial Services |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
